FindTrial
Sign In

Spinal anaesthesia with two different drugs as adjuvants in cesarean section

A prospective observational study of intrathecal hyperbaric ropivacaine with nalbuphine or dexmedetomidine as adjuvants for cesarean section - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/067057
Enrollment
50
Registered
2024-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: NIL: NIL

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients posted for elective or emergency caesarean section receiving spinal anaesthesia Patients in the age group of 18-40 years Patients belonging to ASA grade I, II or III Patients giving written informed consent

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Onset and duration of sensory & motor blockade Duration of post operative analgesia and 24 hours analgesic requirementTimepoint: 24 hours—

Secondary

MeasureTime frame
Sensory assessment: pin prick method Modified Bromage scale Apgar score Visual analogue scale score for pain Ramsay sedation scoreTimepoint: Till 24 hrs after spinal anaesthesia—

Countries

India

Contacts

Public ContactDr.Bansari N kantharia

Government medical College surat new civil hospital surat

bansarikantharia@gmail.com9825690177

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026